Prophylactic Anti-Emetic Effect of Dexamethasone and Metoclopramide on the Nausea and Vomiting Induced by Laparoscopic Cholecystectomy: A Randomized, Double Blind, Placebo-Controlled Trial

A. Khalaj, S. Miri, Mojdeh Porlashkari, A. Mohammadi
{"title":"Prophylactic Anti-Emetic Effect of Dexamethasone and Metoclopramide on the Nausea and Vomiting Induced by Laparoscopic Cholecystectomy: A Randomized, Double Blind, Placebo-Controlled Trial","authors":"A. Khalaj, S. Miri, Mojdeh Porlashkari, A. Mohammadi","doi":"10.5812/JMISS.9434","DOIUrl":null,"url":null,"abstract":"Background: Postoperative nausea and vomiting (PONV) is an unpleasant, distressing and frequent adverse effect after general anesthesia and surgery which has a high incidence in patients undergoing laparoscopic cholecystectomy. While none of the currently available antiemetic drugs are fully effective in all patients, it has been reported that dexamethasone is effective against emesis in patients undergoing general anesthesia. Objectives: This study evaluates the prophylactic anti-emetic effect of dexamethasone in comparison with metoclopramide and placebo for the prevention of post-operative nausea and vomiting in patients undergoing elective laparoscopic cholecystectomy. Patients and Methods: In Mostafa Khomeini hospital, a teaching hospital of Shahed University, Tehran, Iran, a randomized, double-blind and placebo-controlled study on 161 patients undergoing general anesthesia for elective laparoscopic cholecystectomy was run.One hundred sixty one patients (124 females and 37 males) requiring general anesthesia for laparoscopic cholecystectomy were studied. The dexamethasone group (n = 53) received dexamethasone 8mg IV, the metoclopramide group (n = 55) received metoclopramide 10mg IV and the placebo group (n = 53) received 2ml saline IV at the induction of anesthesia. Results: In the current study, 26.4 %, 32.7 % and 52.8 % of patients reported vomiting in the dexamethasone, metoclopramide and placebo group (P≤ 0.001), respectively. The total incidence of nausea and vomiting also reduced to 30.2 % with dexamethasone in comparison with 49.1 % in metoclopramide group and 58.5 % in placebo group. (P ≤ 0.001) Conclusions: Dexamethasone 8mg is a better anti-emetic agent than metoclopramide for the prevention of post-operative nausea and vomiting after laparoscopic cholecystectomy.","PeriodicalId":158928,"journal":{"name":"Journal of Minimally Invasive Surgical Sciences","volume":"4 1","pages":"0"},"PeriodicalIF":0.0000,"publicationDate":"2013-04-05","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"9","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of Minimally Invasive Surgical Sciences","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.5812/JMISS.9434","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 9

Abstract

Background: Postoperative nausea and vomiting (PONV) is an unpleasant, distressing and frequent adverse effect after general anesthesia and surgery which has a high incidence in patients undergoing laparoscopic cholecystectomy. While none of the currently available antiemetic drugs are fully effective in all patients, it has been reported that dexamethasone is effective against emesis in patients undergoing general anesthesia. Objectives: This study evaluates the prophylactic anti-emetic effect of dexamethasone in comparison with metoclopramide and placebo for the prevention of post-operative nausea and vomiting in patients undergoing elective laparoscopic cholecystectomy. Patients and Methods: In Mostafa Khomeini hospital, a teaching hospital of Shahed University, Tehran, Iran, a randomized, double-blind and placebo-controlled study on 161 patients undergoing general anesthesia for elective laparoscopic cholecystectomy was run.One hundred sixty one patients (124 females and 37 males) requiring general anesthesia for laparoscopic cholecystectomy were studied. The dexamethasone group (n = 53) received dexamethasone 8mg IV, the metoclopramide group (n = 55) received metoclopramide 10mg IV and the placebo group (n = 53) received 2ml saline IV at the induction of anesthesia. Results: In the current study, 26.4 %, 32.7 % and 52.8 % of patients reported vomiting in the dexamethasone, metoclopramide and placebo group (P≤ 0.001), respectively. The total incidence of nausea and vomiting also reduced to 30.2 % with dexamethasone in comparison with 49.1 % in metoclopramide group and 58.5 % in placebo group. (P ≤ 0.001) Conclusions: Dexamethasone 8mg is a better anti-emetic agent than metoclopramide for the prevention of post-operative nausea and vomiting after laparoscopic cholecystectomy.
地塞米松和甲氧氯普胺对腹腔镜胆囊切除术后恶心呕吐的预防止吐作用:一项随机、双盲、安慰剂对照试验
背景:腹腔镜胆囊切除术患者术后恶心呕吐(PONV)是全麻及手术后常见的不良反应,发生率高。虽然目前没有一种止吐药物对所有患者都完全有效,但据报道,地塞米松对全身麻醉患者的呕吐有效。目的:本研究比较地塞米松与甲氧氯普胺和安慰剂对选择性腹腔镜胆囊切除术患者术后恶心呕吐的预防作用。患者与方法:在伊朗德黑兰Shahed大学附属医院Mostafa Khomeini医院,对161例全麻择期腹腔镜胆囊切除术患者进行随机、双盲、安慰剂对照研究。对腹腔镜胆囊切除术中需要全身麻醉的161例患者(女性124例,男性37例)进行了研究。地塞米松组(n = 53)在麻醉诱导时给予地塞米松8mg IV,甲氧氯普胺组(n = 55)给予甲氧氯普胺10mg IV,安慰剂组(n = 53)给予生理盐水2ml IV。结果:在本研究中,地塞米松组、甲氧氯普胺组和安慰剂组呕吐发生率分别为26.4%、32.7%和52.8% (P≤0.001)。地塞米松组恶心和呕吐的总发生率也降低到30.2%,而甲氧氯普胺组为49.1%,安慰剂组为58.5%。(P≤0.001)结论:地塞米松8mg在预防腹腔镜胆囊切除术后恶心呕吐方面优于甲氧氯普胺。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
自引率
0.00%
发文量
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信